Candriam S.C.A. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$4,0000.0%95
+3.3%
0.00%
Q3 2021$4,0000.0%920.0%0.00%
Q2 2021$4,000
+33.3%
92
-5.2%
0.00%
Q1 2021$3,000
+200.0%
97
+142.5%
0.00%
Q4 2020$1,0000.0%40
+135.3%
0.00%
Q3 2020$1,0000.0%170.0%0.00%
Q2 2020$1,000
-66.7%
17
-76.1%
0.00%
Q3 2018$3,0000.0%71
+2.9%
0.00%
Q2 2018$3,000690.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2018
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders